Varghese Jose C, Hahn Peter F, Harisinghani Mukesh G, Hayat Sikandar M, Gervais Deborah A, Hooper David C, Mueller Peter R
Department of Radiology and Infectious Diseases Division, Infection Control Unit, Massachusetts General Hospital, 55 Fruit St, White 270-E, Boston, MA 02114, USA.
Radiology. 2005 Aug;236(2):730-8. doi: 10.1148/radiol.2362031044.
To retrospectively evaluate the effectiveness of percutaneous catheter drainage in the treatment of fungus-infected fluid collections in the thorax or abdomen and to identify any factor that may be predictive of a poor clinical outcome.
Approval for this study was obtained from the hospital ethics subcommittee on human studies. Because the study was retrospective, patient informed consent was not required. This study was compliant with the Health Insurance Portability and Accountability Act. Retrospective analysis was performed of cases of fungus-infected fluid collections in the thorax or abdomen treated by using percutaneous catheter drainage in 60 patients (36 male and 24 female patients; mean age, 57 years; range, 2 months to 91 years) during 5 years. The patient medical records were reviewed to identify recognized factors for predisposition to fungal infection. The details of percutaneous catheter drainage and microbiologic findings were recorded. The technical success (ability of catheters placed to drain collections treated) and the clinical success (ability of patients to recover fully without surgery) of percutaneous catheter drainage were determined. A multifactor logistic regression analysis was performed to identify any clinical or microbiologic factor predictive of a poor clinical outcome.
Seventy-three fungus-infected fluid collections were drained in 60 patients. The collections originated from the pleura (n = 6), mediastinum (n = 2), liver (n = 3), pancreas (n = 5), obstructed biliary or urinary tract (n = 9), gallbladder (n = 1), and abdominopelvic area (n = 47). The technical success rate for catheter drainage was 79% (41 of 52 patients); the clinical success rate, 57% (34 of 60 patients). Twenty (33%) patients died from all causes during hospital admission. Multifactor logistic regression analysis was used to identify predictors of a poor clinical outcome; complexity of collection, history of malignancy, and admission to intensive care unit were significant (P < .03) and independent predictors.
Despite a moderately high technical success rate with percutaneous catheter drainage of fungus-infected fluid collections, clinical success rate was much lower. Both imaging appearance (complexity of collection) and clinical factors (history of malignancy, admission to intensive care unit) influenced prognosis.
回顾性评估经皮导管引流术治疗胸腹部真菌性积液的有效性,并确定可能预测临床预后不良的因素。
本研究获得了医院人体研究伦理小组委员会的批准。由于本研究为回顾性研究,因此无需患者知情同意。本研究符合《健康保险流通与责任法案》。对5年间60例(男性36例,女性24例;平均年龄57岁;范围2个月至91岁)采用经皮导管引流术治疗的胸腹部真菌性积液病例进行回顾性分析。查阅患者病历以确定公认的真菌感染易感因素。记录经皮导管引流的详细情况和微生物学检查结果。确定经皮导管引流的技术成功率(放置的导管能够引流所治疗的积液)和临床成功率(患者无需手术即可完全康复的能力)。进行多因素逻辑回归分析以确定任何预测临床预后不良的临床或微生物学因素。
60例患者共引流了73处真菌性积液。积液分别来源于胸膜(n = 6)、纵隔(n = 2)、肝脏(n = 3)、胰腺(n = 5)、梗阻性胆道或泌尿道(n = 9)、胆囊(n = 1)和腹腔盆腔区域(n = 47)。导管引流的技术成功率为79%(52例患者中的41例);临床成功率为57%(60例患者中的34例)。20例(33%)患者在住院期间因各种原因死亡。采用多因素逻辑回归分析确定临床预后不良的预测因素;积液的复杂性、恶性肿瘤病史和入住重症监护病房是显著(P < .03)且独立的预测因素。
尽管经皮导管引流真菌性积液的技术成功率中等偏高,但临床成功率要低得多。影像学表现(积液的复杂性)和临床因素(恶性肿瘤病史、入住重症监护病房)均影响预后。